Received May 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | UNK | — | IM / LA |
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | — | IM / RA |
Patient presents to the pharmacy counter 3 days after receiving first dose of Shingrix vaccine in her right arm and Capvaxive in her left arm. No adverse reactions to the Capvaxive vaccine but patient has injection site reaction to the Shingrix vaccine which includes large area of redness and swelling on her upper arm. She states that it began as a small area but grew to a cover a much larger area. Patient was given recommendations for how to treat reaction at home including taking OTC pain relievers such as Ibuprofen and placing an ice pack on the area to reduce swelling. She stated that she would follow those recommendations and follow up if not improved after a few days.